Difference in drug cost between private and public drug plans in Quebec, Canada.
Drug cost difference
Drug insurance
Drug plan
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
14 Feb 2022
14 Feb 2022
Historique:
received:
02
06
2021
accepted:
03
02
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
17
2
2022
Statut:
epublish
Résumé
We expect a difference in drug cost between private drug plans and the Public Drug Plan (PDP) because the dispensing fee is fixed and regulated by the PDP for publicly insured patients, whereas it is determined freely by the pharmacy owner for privately insured patients. This study compared the drug cost of Quebec residents covered by private drug plans with those covered by PDP. We used a sample of prescriptions filled between 1 January 2015 and 23 May 2019 selected from reMed, a database of Quebecers' drug claims. We created strata of prescriptions filled by privately insured patients and matched them with strata of prescriptions filled by publicly insured patients based on the Drug Identification Number, quantity dispensed, number of days of supply, pharmacy identifier, and a date corresponding to the publication of List of Medications of Régie de l'Assurance Maladie du Québec. The differences in drug cost between private plans and the PDP were analyzed with linear regression models using prescription strata as the unit of analysis. Based on 38 896 prescription strata, we observed that privately insured patients payed $9·35 (95% confidence interval [CI]: 5·58; 13·01) more on average per drug prescription than publicly insured patients, representing a difference of 17·6%. This study showed that, on average, drug cost is substantially higher for privately insured Quebecers. Knowing that adherence to treatment is affected by drug cost, these results will help public health authorities to make informed decisions about drug policies.
Sections du résumé
BACKGROUND
BACKGROUND
We expect a difference in drug cost between private drug plans and the Public Drug Plan (PDP) because the dispensing fee is fixed and regulated by the PDP for publicly insured patients, whereas it is determined freely by the pharmacy owner for privately insured patients. This study compared the drug cost of Quebec residents covered by private drug plans with those covered by PDP.
METHODS
METHODS
We used a sample of prescriptions filled between 1 January 2015 and 23 May 2019 selected from reMed, a database of Quebecers' drug claims. We created strata of prescriptions filled by privately insured patients and matched them with strata of prescriptions filled by publicly insured patients based on the Drug Identification Number, quantity dispensed, number of days of supply, pharmacy identifier, and a date corresponding to the publication of List of Medications of Régie de l'Assurance Maladie du Québec. The differences in drug cost between private plans and the PDP were analyzed with linear regression models using prescription strata as the unit of analysis.
RESULTS
RESULTS
Based on 38 896 prescription strata, we observed that privately insured patients payed $9·35 (95% confidence interval [CI]: 5·58; 13·01) more on average per drug prescription than publicly insured patients, representing a difference of 17·6%.
CONCLUSIONS
CONCLUSIONS
This study showed that, on average, drug cost is substantially higher for privately insured Quebecers. Knowing that adherence to treatment is affected by drug cost, these results will help public health authorities to make informed decisions about drug policies.
Identifiants
pubmed: 35164750
doi: 10.1186/s12913-022-07611-4
pii: 10.1186/s12913-022-07611-4
pmc: PMC8845277
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
200Informations de copyright
© 2022. The Author(s).
Références
Health Aff (Millwood). 2001 Mar-Apr;20(2):74-85
pubmed: 11260961
Can J Cardiol. 2014 May;30(5):560-7
pubmed: 24613090
Health Aff (Millwood). 2001 Jan-Feb;20(1):276-86
pubmed: 11194852
Health Policy. 2005 Feb;71(2):181-93
pubmed: 15607380
J Nurs Scholarsh. 2003;35(3):207
pubmed: 14562485
J Behav Med. 2005 Feb;28(1):43-51
pubmed: 15887875